Safety study of the drug SYH2056 in healthy volunteers
This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 18 and 26.
- You must be in good health without major medical conditions.
- You must be willing to use effective birth control during the study and for 3 months after.
- You must not have taken any prescription or over-the-counter medications, vitamins, or supplements in the 4 weeks before the study.
- You must not smoke more than 5 cigarettes a day or drink more than 14 units of alcohol per week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This trial tests a new inhaler medication to see if it is safe and how the body processes it. It may help in future treatments for lung conditions.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.